baber/WOPTO huggingface dataset:
Patent NZ-512046-A (NZ)
Title: Delivery system for the administration of peptide drugs, vaccines and hormones through oral, nasal and pulmonary membranes
Inventor: MODI PANKAJ
IPC: A61K48/00
Filed: 1999-12-16
Abstract: A mixed liposome pharmaceutical composition with multilamellar vesicles is provided.  The vesicles are comprised of a proteinic pharmaceutical agent, water, an alkali metal lauryl sulphate in a concentration of between 1 to 10 wt/wt%, at least one membrane-mimetic amphiphile and at least one phospholipid. A method of making the composition using high speed mixing of the amphiphiles and phospholipids is also provided.  The composition may be administered to the buccal cavity using a metered dose dispenser.
Patent NZ-513122-A (NZ)
Title: Printed medium activated interactive communication of multimedia information, including advertising
Inventor: ANDERER MICHAEL
IPC: G06Q30/02
Filed: 2000-01-26
Abstract: The present device is described in bridging the gap between the virtual multimedia-based Internet world and the real world, best exemplified by print media. More particularly, the device relates to communicating multimedia information using a scanner (100) for machine-readable code (10) containing a link information corresponding to a provider information (600) depicted on the printed medium (50), a user interface (120) for obtaining user input information corresponding to the provider information, a communication bridge for sending the link information and the user input information via the network, a receiver (180) in communication with the scanner, capable of receiving the link information and the user input information, and further capable of receiving and playing a multimedia information sequence (500), and a portal server (200) in communication with the scanner via the network capable of selecting a multimedia information sequence corresponding to the link information and the user input information.
Patent NZ-514896-A (NZ)
Title: A method of preventing parturient hypocalcemia in animals and compositions used therein
Inventor: JOERGENSEN ROLF JESS
IPC: A23K1/18
Filed: 2000-03-13
Abstract: Method of preventing parturient hypocalcemia and milk fever (parturient paresis) in lactating animals comprising administering to the animal during the dry period a compound that reduces absorption of calcium from the drinking water and/or from the ration of said animal is disclosed. The method is based on the powerful, natural calcium regulating mechanisms and is applicable under commercial farming conditions.
Patent NZ-515788-A (NZ)
Title: Marine partition netting with layer of polyurethane coating incorporating anti-fouling agent non-toxic to marine life
Inventor: EELES JOHN WILLIAM
IPC: A01K63/00
Filed: 2000-05-30
Abstract: Marine netting (10) which comprises a network of grid elements defining an array of openings, the network comprising an array of core elements (12a...12e, 14a...14g), elements (12a...12e, 14a...14g) or array being coated with layer of polyurethane incorporating an anti-fouling agent which is substantially non-toxic to marine life. The netting (10) may be manufactured in an open moulding process or by aligning and joining flexible members comprising a core element (12a) coated in polyurethane.
Patent NZ-516675-A (NZ)
Title: Permanent magnet coupler with adjustable air gaps
Inventor: LAMB KARL J
IPC: H02K49/10
Filed: 2000-08-04
Abstract: A  cage carrying two axially adjustable conductors  is mounted  on  one shaft and a rotor is mounted  on  a  second coaxial  shaft to occupy a position between the  conductors. Permanent  magnets  on the rotor have poles  spaced  by  air gaps  from  the  conductors. The air gaps  are  adjusted  by sliding  the  conductors toward and away  from  one  another along  slide members on the cage by use of adjustment  units engaging   the   conductor   rotors.   Alternatively,    the conductors can be mounted on the rotor, and the magnets  can be adjustably mounted on the cage.
Patent NZ-519469-A (NZ)
Title: Nucleic acid probes for detecting the presence of Mycobacterium paratuberculosis and distinguishing between cattle and sheep strains
Inventor: COLLINS DESMOND MICHAEL
IPC: C12Q1/68
Filed: 2002-06-10
Abstract: An isolated nucleic acid molecule of a sheep type of M. paratuberculosis comprises the sequence of SEQ ID NO:1. The nucleic acid can be used in a method for detecting the presence of M. paratuberculosis in a sample via nucleic acid amplification. Probes of SEQ ID NO:1 or SEQ ID NO:2 can be used to determine whether a strain of either sheep type of cattle type of M. paratuberculosis is present in a sample, to distinguish any strain of M. paratuberculosis from any other strain of M. tuberculosis or the MAI complex present in a sample and to detect the presence of M. paratuberculosis as a causative agent of Johne's disease or Crohn's disease.
Patent NZ-522045-A (NZ)
Title: RNA sequence-specific mediators of RNA interference
Inventor: SHARP PHILLIP A
IPC: A61K48/00
Filed: 2001-03-30
Abstract: Disclosed is a Drosophila in vitro system which is useful to demonstrate that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Furthermore, when these 21-23 nt fragments are purified and added back to Drosophila extracts, they mediate RNA interference in the absence of long dsRNA. Thus, these 21-23 nt fragments are the sequence-specific mediators of RNA degradation. A molecular signal, which may be their specific length, must be present in these 21-23 nt fragments to recruit cellular factors involved in RNAi. The system encompasses these 21-23 nt fragments and their use for specifically inactivating gene function. The use of these fragments (or chemically synthesized oligonucleotides of the same or similar nature) enables the targeting of specific mRNAs for degradation in mammalian cells, where the use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response. This specific targeting of a particular gene function is useful in functional genomic and therapeutic applications.
Patent NZ-524464-A (NZ)
Title: Process for preparation of anhydrous azithromycin
Inventor: SINGH SHIVA P
IPC: C07H17/08
Filed: 2001-08-23
Abstract: A process for preparing an anhydrous compound having formula I wherein R1 represents hydrogen , (C1-C6)- alkyl, (C6-C10)-aryl or (C7-C16)-aralkyl wherein the R2, R3, R4, R5 and R6 groups individually are hydrogen or (C1-C4)- alkyl; comprising removing an organic solvent or an organic solvent and water from a solution comprising a hydrated compound of formula I in the organic solvent or the solution of a hydrated compound of formula I in the mixture of the organic solvent and water so as to provide the anhydrous compound.
Patent NZ-525150-A (NZ)
Title: Preventives and remedies for complications of diabetes
Inventor: KITAHARA MASAKI
IPC: A61P9/00
Filed: 2001-10-11
Abstract: Preventives and remedies for complications of diabetes which contain as the active ingredients compounds of formula (I) or lactone derivatives thereof are disclosed, wherein R represents an organic group; X represents CH2CH2- or CH=CH-; and M represents hydrogen, C1-10 alkyl or a physiologically acceptable cationic group. These drugs are useful in preventing and treating complications of diabetes such as diabetic nephropathy, diabetic neuropathy, diabetic retinopathy and diabetic angiopathy.
Patent NZ-525345-A (NZ)
Title: A scaffolding plank
Inventor: RUMBALL MAURICE
IPC: E04G5/08
Filed: 2003-04-15
Abstract: A scaffold plank including a wooden plank encased within a fiberglass covering.
Patent NZ-531191-A (NZ)
Title: Glyphosate composition
Inventor: HOWAT PETER DUNLOP
IPC: A01N25/30
Filed: 2002-07-31
Abstract: Disclosed is a glyphosphate composition comprising a mixture of salts of glyphosphate, comprising each of potassium and isopropylammonium salts. The composition may also optionally comprise further cations, surfactants and the monoethanolammonium salt of glyphosphate.
Patent NZ-532591-A (NZ)
Title: Antibody capable of specifically binding a single type of TNF-related apoptosis-inducing ligand (TRAIL) receptor, and a monoclonal antibody that induces apoptosis in vivo and in vitro cells expressing the single type receptor and therapies based thereon
Inventor: ZHOU TONG
IPC: A61K41/00
Filed: 2002-11-01
Abstract: Disclosed is a purified antibody which specifically binds a TRAIL receptor DR4, wherein said antibody, in its soluble form, has in vivo and in vitro apoptosis-inducing activity in target cells expressing DR4, and wherein the antibody does not bind DR5, DcR1 and DcR2.
Patent NZ-534312-A (NZ)
Title: Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
Inventor: LIM JONG
IPC: A61K31/4015
Filed: 2003-01-28
Abstract: Disclosed is a method for the manufacture of a pharmaceutical tablet that upon ingestion delivers a first drug by immediate release and a second drug by sustained release, defined as a release rate into gastric fluid that is slow enough to leave at least 40% of the second drug unreleased one hour after ingestion, and in which the first drug is at most sparingly soluble in water and the weight ratio of the first drug to the second drug is equal to or less than 0.01:1, the method comprising: (a) dispersing the second drug in a solid matrix to form a unitary core that upon immersion in gastric fluid releases the second drug by sustained release while retaining at least a portion of the mass of the solid matrix as a coherent body until the second drug is fully released, (b) depositing on the second surface of the unitary core an aqueous suspension of particles of the first drug that are equal to or less than 10 microns in diameter, (c) evaporating water from the aqueous suspension thus deposited to leave a solid shell encasing the unitary core and containing the first drug. Or alternatively: (a) combining the second drug with a slid first matrix to form a sustained release layer, the first solid matrix being of a substance that when formed into a coherent body and immersed in gastric fluid releases the second drug by sustained release while retaining at least a portion of the mass of the first solid matrix as a coherent body until the second drug is fully released, and (b) combining particles of the first drug that are equal to or less than about 10 microns in diameter with particles of a second solid matrix to form an immediate release layer adjoined to the sustained-release layer as a layered tablet, the second solid matrix being of a substance that separates into discrete matrix particles immediately upon immersion in gastric fluid.
Patent NZ-535662-A (NZ)
Title: N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors
Inventor: ARANYI PETER
IPC: A61P13/12
Filed: 2003-03-04
Abstract: Disclosed are N-aminoacetyl-pyrrolidine-2-carbonitriles of the general formula (I) wherein R1 is as defined in the specification, R2 stands for hydrogen atom or fluorine atom and R3 stands for fluorine atom. Pharmaceutical formulations of these compounds are suitable to inhibit the activity of DPP-IV enzyme and intended for the treatment and the prevention of diseases related with DPP-IV enzyme activity, such as diabetes.
Patent NZ-535988-A (NZ)
Title: Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
Inventor: JIA QI
IPC: A61K31/05
Filed: 2003-04-30
Abstract: A composition of matter comprised of a mixture of two specific classes of compounds Free-B-ring flavonoids and flavans suitable for use in the prevention and treatment of diseases and conditions mediated by the COX-2 and 5-LO pathways is disclosed. Also described is a method for simultaneously inhibiting the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) enzymes, and reducing cox-2 mRNA production; and a method for weight loss and blood glucose control. This composition is suitable for the prevention and treatment of diseases and conditions mediated by the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) pathways, including joint discomfort and pain associated with conditions such as osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse.
Patent NZ-539228-A (NZ)
Title: High corrosion-resistant hot dip coated steel product excellent in surface smoothness and formability, and method for producing hot dip coated steel product
Inventor: HONDA KAZUHIKO
IPC: C23C2/06
Filed: 2003-10-27
Abstract: Disclosed is a highly corrosion-resistant hot-dip galvanised steel product, excellent in surface smoothness and formability, having on the steel product surface a zinc allow plating layer of 4-10% Al, 1-5% Mg, up to 0.1% Ti, 0.00001-0.5% Si, and the balance of Zn and unavoidable impurities. The plating layer having a metal structure in which one or at least two of the [Al phase], [Zn2Mg phase] and [Zn phase] are present in a mixture in the matrix of an [Al/Zn/Zn2Mg] ternary eutectic structure, and plating layer containing a Ti-Al base intermetallic compound in one or at least two of the [Al phase], [Zn2Mg phase] and [Zn phase].
Patent NZ-540525-A (NZ)
Title: Mixing chamber
Inventor: ZHA FUFANG
IPC: B01D65/02
Filed: 2003-12-05
Abstract: A membrane module (5) including a plurality of porous membranes (6) extending in an array and mounted, at least at one end, in a header (8). The header (8) has a number of distribution apertures (11) for distributing a fluid into the module (5) and along a surface or surfaces of the membranes (6). An elongate chamber (10) having one open end (13) and another end is in fluid communication with the distribution apertures (11) for distributing the fluid to the distribution apertures (11).
Patent NZ-541470-A (NZ)
Title: Improvements in or relating to safety covers for electric sockets and the like
Inventor: O'CONNELL IAN
IPC: H01R13/639
Filed: 2004-01-27
Abstract: An electrical socket comprises a wall mounted faceplate (17) with pin receiving apertures for a plug and an integral (built-in) cover having a cover panel (22) movable between an open position allowing access to the apertures and a closed position concealing the apertures. The cover panel (22) is secured in the closed position by engagement of latch pins (64) with latching means within the faceplate (17). The latch pins (64) are released by a key inserted into keyholes (66) in the side of the faceplate (17) and opens automatically under the biasing of a spring.
Patent NZ-541983-A (NZ)
Title: Method of forming a housing by rotation moulding around an antenna
Inventor: LAWRENCE RODNEY JOHN
Filed: 2005-08-23
Abstract: Disclosed is a method of forming a housing that encompasses an antenna which is located within a mould, and then a plastic material is introduced into the mould. Next the mould is rotated to form a plastic exterior surface of a housing on the internal surface of the mould with the internal surface being located inside the exterior surface of the housing formed.
Patent NZ-543245-A (NZ)
Title: Use of water-soluble crosslinked cationic polymers for controlling deposition of pitch and stickies in papermaking
Inventor: SONG ZHIQIANG
IPC: D21H21/02
Filed: 2004-04-29
Abstract: Disclosed is a method of controlling pitch and stickies deposition in papermaking, which method comprises the step of adding to paper furnish prior to sheet formation a multi-crosslinked cationic polymer, which polymer is prepared by the method comprising: (i) polymerizing substantially all of the monomer components by free radical initiation to form a base cationic polymer solution, wherein at least one of the monomer components is a cationic monomer component; and (ii) contacting the base cationic polymer solution with additional free radical initiator to form interconnecting bonds between the base cationic polymers to form the multi-crosslinked cationic polymer, wherein the multi-crosslinked cationic polymer has a higher molecular weight than the base cationic polymer.
Patent NZ-545283-A (NZ)
Title: Methods and compositions for determining a subject's predisposition to developing impaired lung function
Inventor: YOUNG ROBERT PETER
IPC: C12Q1/68
Filed: 2002-06-05
Abstract: Method of determining a subject's predisposition to developing a condition, of determining a subject's potential risk of developing the condition or of diagnosing in a subject the potential on set of the condition, the method comprising at least the analysis of at least one polymorphism chosen from the group consisting of: A-82G in the promoter of the gene encoding MMP12 (human macrophage elastase); T--àC within codon 10 of the gene encoding TGFbeta (transforming growth factor beta); C+760G of the gene encoding SOD3 (Superoxide dismutase 3); T-1296C within the promoter of the gene encodingTIMP3 (tissue inhibitor of metalloproteinase 3); 1G/2G at position -1607 within the promoter of MMP1 (interstitial collagenase); C-1562T in the promoter of the gene encoding MMP9 (gelatinase B); or one or more polymorphisms in linkage disequilibrium with one or more of these polymorphisms; wherein the genotype of the subject is indicative of predisposition to developing the condition, of potential risk of developing the condition or of the potential on set of the condition, and wherein the condition is chronic obstructive pulmonary disease or impaired lung function.
Patent NZ-546038-A (NZ)
Title: Liquid dish cleaning compositions
Inventor: SZEWCZYK GREGORY
IPC: C11D1/75
Filed: 2004-08-27
Abstract: A liquid dish cleaning composition is disclosed, which comprises approximately by weight: (a) 1% to 6% of a sodium salt of a C8-C16 linear alkyl benzene sulfonated surfactant; (b) 7% to 13% of a magnesium salt of a C8-C16 linear alkyl benzene sulfonated surfactant; (c) 8% to 14% of an ammonium or sodium salt of an ethoxylated C8-C18 alkyl ether sulfate surfactant having 1 to 3 moles of ethylene oxide; (d) 8% to 14% of an ammonium or sodium salt of an ethoxylated C8-C18 alkyl ether sulphate surfactant having 5 to 10 moles of ethylene oxide; (e) 3% to 10% of an amine oxide .surfactant; (f) from 0 to 5% of a hydroxy containing organic acid; (g) from 0 to 10% of at least one solubilizing agent; and (h) water, wherein the composition has a pH of 3 to 7 and has a viscosity of 100 to 1,000 cps at 25 Deg. C using a #2 spindle at 20 rpm as measured on a Brookfield RVTDV-II viscometer; and wherein the cleaning composition does not include an alkali metal silicate or alkali metal builder.
Patent NZ-551639-A (NZ)
Title: Air pollution control
Inventor: HURLEY PETER J
IPC: B01D53/60
Filed: 2005-04-29
Abstract: Disclosed is a method for controlling air pollution, comprising allowing a combustion gas to contact an aqueous, 20-50% w/w solids dispersion of an alkaline-earth metal sulfide and a buffering agent, wherein the buffering agent is selected from the group consisting of phosphoric acid, salts of phosphoric acid, alkaline-earth metal-based pH buffers, and mixtures thereof. Also disclosed is a composition for removing a heavy metal from a combustion gas, comprising an aerosolised, aqueous dispersion or an aerosolized slurry of an alkaline-earth metal sulfide and a buffering agent.
Patent NZ-553239-A (NZ)
Title: Process for concentration of antibodies and proteins
Inventor: WINTER CHARLES MATTHEW
IPC: C07K1/34
Filed: 2005-09-08
Abstract: Disclosed is a process for preparing a highly concentrated protein composition comprising: a) a first ultrafiltering of a first protein preparation to provide a second protein preparation; b) a diafiltering of the second protein preparation to provide a diafiltered intermediate protein preparation; and c) a second ultrafiltering of the diafiltered intermediate protein preparation to provide a third protein preparation; wherein one or more of the first ultrafiltering, the second ultrafiltering, and the diafiltering are accomplished at about 30°C to about 50°C.
Patent NZ-554659-A (NZ)
Title: Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
Inventor: LIU JIA
IPC: A61K31/55
Filed: 2005-09-12
Abstract: Disclosed is a crystalline phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one (the pictured formula), wherein the salt is one of six substantially pure polymorph with X-ray powder diffraction patterns as described in the specification. Also disclosed is the use of the salt for treating cancer.
Patent NZ-556008-A (NZ)
Title: A combined table cover and food protection unit
Inventor: BRAITHWAITE DOREEN TUI
Filed: 2007-06-21
Abstract: A combined table cover/food protection unit. The fabric tabletop cover (1) has an elastized hem (2) for secure attachment to the table top. The hem has a number of fasteners connected to the hanging end, the fasteners used when the unit is in its food protection position to securely hold the protective sides in position. Sides (3) can be pulled up over the tabletop and connected together with fasteners to form a food protection unit. Flexible spacers (5), concealed within envelopes along the length of the sides provide structural stiffness to the food protection unit. Optional window features provide access to the table top when the food protection sides are in their upright position.
Patent NZ-563387-A (NZ)
Title: A support base, typically for road sign, with foldable legs and socket and spigot upwardly extending to support tubular object in particular orientation
Inventor: SMYTH ALLEN TRAVERS
IPC: A47F5/00
Filed: 2007-11-13
Abstract: Support base 1 is for upstanding items such as road signs and has a sleeve 2, a base structure 3 consisting of lower and upper base plates, and at least three legs extending out from the base structure and being foldable to a collapsed and substantially "flat" position of the support base (by typically not extending more than 150mm vertically when knocked over). The lower base plate has a means for orienting the upstanding item in a particular orientation, typically in the form of a truncated pyramid shape (not shown) centred on and within the spigot so as to prevent rotation of a square section tubular member of the upstanding item. Further details such as handle 5, bends B in legs and wheels on ends of legs (not shown) are disclosed.
Patent NZ-578564-A (NZ)
Title: Simultaneous multiple acervation process
Inventor: LOH JIMBAY PETER
IPC: A23L29/20
Filed: 2009-07-22
Abstract: Disclosed is a method for producing a structured polymer matrix, the method comprising: preparing at least one aqueous solution containing one or more food polymers, wherein the one or more food polymers are capable of undergoing at least two acervation mechanisms, and wherein conditions are such that the at least two acervation mechanisms are not activated prior to an activation step; treating the at least one aqueous solution containing one or more food polymers to activate that at least two acervation mechanisms simultaneously; and allowing the at least two activated acervation mechanisms to proceed until the structured polymer matrix is obtained.
Patent NZ-579384-A (NZ)
Title: Cuff for Air Delivery Conduit with connector end with internal taper and resilient bead for sealing
Inventor: VIRR ALEXANDER
IPC: A61M16/08
Filed: 2009-09-01
Abstract: A cuff for an air delivery conduit includes a first end portion provided to a tube and a second end portion adapted to engage a tubular connector. The second end portion includes an entry surface that is curved or chamfered along its length to provide a lead in for inserting the second end portion onto the tubular connector in use. The entry surface provides an internal diameter that is larger than an external diameter of the tubular connector, and the second end portion has a resilient bead so as to provide a friction fit and a gas seal.